Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in
Ultragenyx Pharmaceutical Inc banner

Ultragenyx Pharmaceutical Inc
NASDAQ:RARE

Watchlist Manager
Ultragenyx Pharmaceutical Inc Logo
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
Watchlist
Price: 21.71 USD -2.25% Market Closed
Market Cap: $2.1B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Cash Flow Statement

Operating Cash Flow
+
3Y
-22%
5Y
-252%
10Y
-340%
Investing Cash Flow
+
3Y
-
5Y
-
10Y
-
Financing Cash Flow
+
3Y
-5%
5Y
-20%
10Y
+2%

Cash Flow Statement
Ultragenyx Pharmaceutical Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Operating Cash Flow
Net Income
(23)
(25)
(29)
(35)
(42)
(47)
(54)
(60)
(68)
(84)
(107)
(146)
(177)
(204)
(230)
(246)
(261)
(277)
(292)
(302)
(204)
(183)
(192)
(198)
(325)
(371)
(397)
(403)
(425)
(301)
(256)
(187)
(204)
(351)
(356)
(454)
(470)
(506)
(678)
(707)
(719)
(721)
(635)
(607)
(613)
(585)
(559)
(569)
(550)
(533)
(580)
(575)
Depreciation & Amortization
0
0
0
0
0
0
1
1
1
1
1
1
2
2
3
3
4
4
4
6
11
16
19
20
16
12
9
9
9
10
11
12
13
13
13
13
14
15
17
18
19
20
23
26
30
33
35
36
36
35
35
35
Change in Deffered Taxes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(16)
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
(2)
0
0
0
(2)
0
0
0
0
0
0
0
0
Stock-Based Compensation
1
1
1
1
1
2
4
5
7
11
17
25
33
38
44
48
53
59
62
68
72
75
79
80
82
84
83
82
82
82
83
86
90
95
101
105
110
119
128
130
133
132
131
135
140
145
152
158
161
160
156
153
Other Non-Cash Items
1
2
3
5
9
10
12
12
11
16
22
31
39
45
51
55
58
59
57
63
(58)
(92)
(86)
(88)
39
70
66
65
63
(15)
6
(63)
(30)
102
71
165
157
142
258
249
246
229
138
121
108
106
101
106
111
101
100
97
Change in Working Capital
2
1
0
(2)
(3)
(2)
0
2
4
9
6
8
3
1
22
26
23
28
11
(4)
(15)
(33)
(42)
(25)
(27)
(20)
(8)
(18)
6
135
95
105
25
(112)
(75)
(63)
2
40
59
62
35
14
(5)
(13)
(31)
(22)
6
14
13
(25)
(1)
(23)
Cash from Operating Activities
(19)
N/A
(22)
-16%
(25)
-15%
(31)
-24%
(36)
-14%
(38)
-6%
(42)
-11%
(45)
-6%
(52)
-16%
(58)
-13%
(78)
-34%
(106)
-36%
(133)
-26%
(156)
-17%
(154)
+1%
(161)
-5%
(177)
-10%
(186)
-5%
(220)
-18%
(254)
-16%
(282)
-11%
(309)
-10%
(317)
-2%
(291)
+8%
(297)
-2%
(310)
-4%
(329)
-6%
(345)
-5%
(345)
+0%
(168)
+51%
(142)
+16%
(132)
+7%
(196)
-49%
(349)
-78%
(347)
+1%
(339)
+2%
(297)
+12%
(309)
-4%
(344)
-12%
(380)
-10%
(420)
-10%
(459)
-9%
(481)
-5%
(475)
+1%
(509)
-7%
(469)
+8%
(419)
+11%
(414)
+1%
(390)
+6%
(421)
-8%
(446)
-6%
(466)
-5%
Investing Cash Flow
Capital Expenditures
(1)
(0)
(0)
(0)
(1)
(2)
(2)
(2)
(2)
(2)
(3)
(5)
(6)
(10)
(11)
(10)
(9)
(5)
(3)
(3)
(3)
(4)
(4)
(4)
(7)
(11)
(15)
(25)
(36)
(35)
(36)
(44)
(46)
(62)
(77)
(73)
(119)
(130)
(135)
(146)
(109)
(94)
(72)
(47)
(35)
(23)
(21)
(20)
(23)
(21)
(21)
(21)
Other Items
(15)
(58)
(59)
(47)
(97)
(81)
(93)
(121)
(60)
(144)
(272)
(287)
(261)
(121)
76
101
68
19
(5)
58
(2)
(33)
(47)
(29)
(57)
(59)
8
12
29
0
(174)
(135)
(220)
(159)
(90)
(122)
69
200
84
(146)
(34)
(28)
176
215
186
135
(207)
2
31
39
432
257
Cash from Investing Activities
(16)
N/A
(58)
-258%
(59)
-1%
(48)
+19%
(98)
-105%
(83)
+16%
(95)
-15%
(123)
-30%
(62)
+50%
(146)
-135%
(276)
-89%
(292)
-6%
(267)
+9%
(132)
+51%
65
N/A
91
+41%
59
-36%
15
-75%
(8)
N/A
55
N/A
(5)
N/A
(37)
-653%
(51)
-37%
(33)
+34%
(63)
-90%
(70)
-10%
(7)
+90%
(13)
-93%
(7)
+46%
(35)
-397%
(210)
-505%
(179)
+15%
(266)
-49%
(222)
+17%
(167)
+25%
(195)
-17%
(50)
+74%
70
N/A
(51)
N/A
(292)
-472%
(143)
+51%
(123)
+14%
103
N/A
168
+62%
151
-10%
112
-26%
(228)
N/A
(18)
+92%
8
N/A
18
+138%
411
+2 146%
236
-43%
Financing Cash Flow
Net Issuance of Common Stock
89
89
74
0
129
129
189
189
236
239
467
468
292
290
38
87
156
158
122
141
359
370
394
337
404
400
376
365
67
94
112
601
558
534
523
119
108
101
95
11
8
35
60
388
389
741
720
392
392
91
87
86
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(5)
0
0
0
0
0
0
0
0
(0)
(0)
(0)
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Paid for Dividends
0
0
0
0
(4)
(4)
(4)
(4)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
51
0
0
25
0
0
0
0
0
0
0
0
314
0
0
0
(0)
(0)
(0)
0
(0)
(1)
(1)
490
490
491
491
(0)
(0)
(0)
0
7
7
0
0
0
392
Cash from Financing Activities
89
N/A
89
+0%
74
-17%
0
-100%
124
+72 965%
124
0%
185
+49%
185
+0%
236
+28%
239
+1%
467
+95%
468
+0%
292
-37%
290
-1%
65
-78%
139
+115%
207
+50%
209
+1%
147
-30%
136
-7%
354
+160%
365
+3%
389
+6%
337
-13%
404
+20%
400
-1%
376
-6%
679
+81%
381
-44%
408
+7%
426
+4%
600
+41%
557
-7%
534
-4%
523
-2%
119
-77%
108
-9%
101
-6%
585
+481%
501
-14%
499
0%
526
+5%
59
-89%
388
+553%
389
+0%
741
+91%
727
-2%
399
-45%
399
+0%
98
-75%
87
-11%
478
+449%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
0
1
1
0
(0)
(0)
(1)
0
(0)
(0)
(1)
(0)
1
1
1
1
0
(1)
(1)
(2)
(3)
(1)
(1)
0
1
0
(0)
(1)
1
(3)
(0)
3
2
4
Net Change in Cash
54
N/A
9
-83%
(10)
N/A
(79)
-690%
(9)
+88%
4
N/A
47
+1 099%
17
-64%
123
+625%
35
-72%
113
+225%
69
-39%
(107)
N/A
3
N/A
(24)
N/A
69
N/A
89
+29%
37
-58%
(81)
N/A
(62)
+24%
67
N/A
19
-72%
22
+13%
12
-42%
43
+243%
21
-52%
40
+93%
321
+706%
29
-91%
204
+605%
75
-63%
290
+287%
95
-67%
(36)
N/A
9
N/A
(417)
N/A
(240)
+42%
(140)
+42%
187
N/A
(172)
N/A
(65)
+62%
(55)
+15%
(318)
-477%
82
N/A
31
-62%
383
+1 140%
82
-79%
(35)
N/A
17
N/A
(302)
N/A
54
N/A
252
+363%
Free Cash Flow
Free Cash Flow
(20)
N/A
(22)
-10%
(26)
-16%
(32)
-24%
(36)
-15%
(39)
-8%
(44)
-12%
(47)
-7%
(54)
-15%
(60)
-12%
(81)
-35%
(111)
-36%
(139)
-25%
(166)
-19%
(165)
+0%
(171)
-4%
(186)
-9%
(191)
-2%
(222)
-16%
(257)
-15%
(285)
-11%
(313)
-10%
(320)
-2%
(295)
+8%
(304)
-3%
(320)
-6%
(344)
-7%
(370)
-8%
(381)
-3%
(203)
+47%
(178)
+13%
(176)
+1%
(243)
-38%
(411)
-70%
(424)
-3%
(412)
+3%
(416)
-1%
(438)
-5%
(480)
-9%
(527)
-10%
(529)
0%
(553)
-5%
(553)
0%
(522)
+6%
(544)
-4%
(492)
+9%
(440)
+11%
(434)
+1%
(413)
+5%
(442)
-7%
(466)
-5%
(487)
-4%

See Also

Summary
RARE intrinsic value, competitors valuation, and company profile.
DCF Valuation
RARE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RARE stock valuation using valuation multiples.
Wall Street Estimates
RARE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RARE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 323,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett